Released Today: New Insight into Root Cause of Auditory Hallucinations in Schizophrenia

Printer-friendly versionPrinter-friendly version
Stanislav S. Zakharenko, M.D., Ph.D. - Brain & behavior research expert on schizophrenia
Dr. Zakharenko

A study by former NARSAD Young Investigator Grantee Stanislav S. Zakharenko, M.D., Ph.D., and his colleagues at St. Jude Children’s Research Hospital in Memphis, Tennessee, proposes that signaling errors in neurons originating in an area of the brain (the thalamus) that sends signals on to the auditory cortex for processing of sound might underlie auditory hallucinations in schizophrenia. The researchers used a mouse model of a developmental disorder closely linked to schizophrenia to try to identify the molecules and brain circuits that might underlie hallucinations.

The absence, or deletion, of a small piece of chromosome 22 is known to cause a developmental disorder—22q11.2 deletion syndrome—that is characterized by heart and palate abnormalities, intellectual disability, and a wide range of other abnormalities. This deletion syndrome also carries a high risk for developing schizophrenia; for this reason researchers often study the deletion syndrome as a genetic model of the illness.

This new study, published online June 6th in Science, reports that a mouse model of 22q11.2 deletion syndrome contained signaling deficits in neurons that connect the thalamus—the “relay station” of the brain that sends information from sensory systems to the parts of the cortex that interprets the signals—to the auditory cortex, where sounds are decoded. These decreased signals were specific to cells originating from the thalamus; they were not found in other neurons in the auditory cortex.

The researchers observed these signaling problems while measuring the electrical activity of neurons in brain slices obtained from the 22q11.2 deletion mouse model. Bathing the slices in antipsychotic medications reversed the deficits. The researchers report that this may offer new insight into how antipsychotic medications effectively treat auditory hallucinations—by correcting the malfunction of these neurons originating in the thalamus—and may offer a new target of neuronal malfunction underlying schizophrenia-associated psychosis.

The research is "a significant advance" in studying 22q11 deletion syndrome, said Columbia University researcher and two-time NARSAD Grantee Christoph Kellendonk, Ph.D., who was not involved in the study. But he cautioned against drawing conclusions about schizophrenia from the data. No direct cause-and-effect link between the signaling abnormalities and auditory hallucinations has yet been made. Further studies will be required to learn more.

Read more about this research on the Schizophrenia Research Forum.

Read the abstract for this research.

Article comments

My experience has been that the "voices" are too "intelligent' and focused to be random mis-firings of the brain. I have Thought Broadcasting and Persecutory Guilt stemming from my experiences with men who tried to indoctrinate me into a Gay lifestyle. I feel in my case these voices are my own mind punishing me for giving in and experiencing same-sex attraction which did begin in my youth. I know there's much more to learn and I'm glad for anti-psychotic medicines and counseling. It's been 33 years since my diagnosis and I'm glad I made it this far. Aloha~ C

Add new comment

comments

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Please note that researchers cannot give specific recommendations or advice about treatment; diagnosis and treatment are complex and highly individualized processes that require comprehensive face-to- face assessment. Please visit our "Ask an Expert" section to see a list of Q & A with NARSAD Grantees.
By submitting this form, you accept the Mollom privacy policy.